Journal Article Summary
The article investigates how proton-pump inhibitors (PPIs), specifically omeprazole and pantoprazole, affect the levels of voriconazole, an antifungal medication. This topic is important because voriconazole is metabolized by the CYP2C19 enzyme, which can be inhibited by PPIs, potentially impacting its effectiveness. Understanding this interaction can help healthcare providers make better decisions regarding the use of PPIs in patients who are being treated with voriconazole.
In this study, researchers observed 78 patients who were divided into four groups based on their PPI treatment: those taking omeprazole, pantoprazole, esomeprazole, and a control group not taking any PPI. The findings revealed that patients not on PPIs had similar voriconazole plasma concentrations compared to those on PPIs. However, patients taking pantoprazole had significantly lower voriconazole levels compared to those taking omeprazole, indicating that omeprazole has a stronger effect on inhibiting the CYP2C19 enzyme.
The study has some limitations, including a small sample size for the esomeprazole group and the observational nature of the research, which may affect the reliability of the findings. Patients should be aware of these interactions and discuss any concerns with their healthcare provider, especially if they are prescribed voriconazole along with a PPI. It is essential to ensure that the chosen PPI does not interfere with the effectiveness of voriconazole treatment.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Blanco Dorado Sara, Maroñas Amigo Olalla, Latorre‐Pellicer Ana, Rodríguez Jato María Teresa, López‐Vizcaíno Ana, Gómez Márquez Aurea, Bardán García Belén, Belles Medall Dolores, et al.. A multicentre prospective study evaluating the impact of proton‐pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations. British Journal of Clinical Pharmacology 2020. DOI: 10.1111/bcp.14267. PMID: 32110830. PMCID: PMC8176997.
Featured Pill Pals Product
Omeprazole 20 mg Capsules --- 30 Count --- Generic for Prilosec --- Xiromed Pharma
Omeprazole 20 mg Capsules — 30 Count — Generic for Prilosec — Xiromed Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
